ANTISENSE-OLIGONUKLEOTIDMODULATION DER RAF-GENEXPRESSION

European patent · EP0863911 · Deleted

Register entry

Publication number
EP0863911
Application number
EP96916859
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 31, 1996
Published
Sep 16, 1998
Granted
Apr 24, 2002
Deleted
May 31, 2015
Reason
Annual fee unpaid
IPC classes
C07H 21/00 (2006.01)
A61K 31/70 (2006.01)
Priority
US 463912 05.06.1995
PCT application
PCT/US1996/008165 31.05.1996
PCT publication
WO1996/039415 12.12.1996
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 23, 2015

    Deleted, fee unpaid

    Published in Swissreg on 23.12.2015

  2. May 30, 2003

    Transferred

    Owner
    ISIS PHARMACEUTICALS, INC., 2292 Faraday Avenue, Carlsbad, CA 92008, USA, Novartis AG, Lichtstrasse 35, 4056 Basel → ISIS PHARMACEUTICALS, INC., 2292 Faraday Avenue, Carlsbad, CA 92008, USA

    Published in +pat+ No 10 in 2003

  3. May 30, 2003

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 10 in 2003

  4. Apr 30, 2002

    Granted

    Published in PIDTJ No 8 in 2002

Parties

Inventor

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.